SUSTAINABILITY: Medicines

Sustainable healthcare sector-focused portfolio that selects drug development companies based on the clinical value added of their medicines. Each company is analysed on medicine-by-medicine and clinical trial-by-clinical trial basis to identify innovators that are making the biggest positive impact on public health worldwide. Portfolio aims to unite attractive financial reward from valuable effective therapeutics with measurable social return from impact on public health. The universe is medium to large drug development companies that have brought at least one medicine to the market.